Note 3 - Consolidation of Variable Interest Entity (Tables)

6 Months Ended

Jun. 30, 2016

Notes Tables

Equity Method Investments [Table Text Block]

	June 30, 2015 Pro Forma
Total revenue	$	4,590,067
Cost of products sold		1,507,552
Gross Profit		3,082,515
Selling, general and administrative expenses		6,148,121
Research and development expenses		384,752
Operating expenses		6,532,873
Loss from operations		(3,450,358	)
Other expenses		-
Interest income		(3,412	)
Total other expenses, net		(3,412)
Loss before provision for income tax and equity in net earnings of equity investments		(3,453,770	)
Provision for Income Tax		(13,646	)
Loss before equity in net earnings of equity investments		(3,467,416	)
Loss on earnings from Milestone Medical		-
Loss on earnings from Education Joint Venture		-
(Loss) Gain on earnings from China Joint Venture		(63,979	)
Loss in equity investments		(63,979	)
Net loss		(3,531,395	)
Less: Net loss attributable to the noncontrolling interests		1,038,888
Net loss attributable to Milestone Scientific Inc.	$	(2,492,507	)